«
»

Top

Tailoring cancer treatment to genetic profile extends lives, study finds

Published 19 Jun 2018 • Updated 23 May 2019 • By Josephine O'Brien

Tailoring cancer treatment to genetic profile extends lives, study finds

A long-term ‘precision medicine’ study found improved outcomes when doctors engage in genetic sequencing of patients’ tumors

Cancer patients with diseases that are difficult to treat may live longer if doctors engage in genetic sequencing and then match treatment to their illness, a long-term “precision medicine” study has found.

The study represents part of a push in cancer treatment to personalize medicine for specific patients, matching known tumor mutations to treatments in an effort to extend patients’ lives. It is the first long-term study to compare tailored methods to traditional, more generic treatment.

“All patients should have access to next generation sequencing and I believe in the next few years we are going to see this approach dramatically improving outcomes,” said Apostolia Maria Tsimberidou, a professor at the University of Texas MD Anderson Cancer Center, who led the research.

“We need to know what is really causing these diseases so we can treat them properly.”

The study was presented at the annual meeting of the American Society of Clinical Oncology (Asco) in Chicago, the world’s largest gathering of cancer specialists.

The study looked at more than 3,700 people with cancer that had proved difficult to treat and who had already undergone other types of treatments. Their ages ranged from 16 to 86, with a median of 57.

Included in the study were gastrointestinal (24.2%), gynecological (19.4%), breast (13.5%), skin (11.9%) and lung (8.7%) cancers.

Of those patients, 1,307 had a known mutation, and 711 received treatment based on that genetic profile. Those patients were twice as likely to live three years (15%) versus those who did not receive tailored treatments (7%). Patients were also six times more likely to live 10 years if they received tailored treatment, at 6% of the sample compared with just 1% for those who received general treatment.

Another, more comprehensive trial is due to take place at the MD Anderson Cancer Center, which will address an admitted shortcoming in the previous study, by using randomized trials.

Tsimberidou said her own clinic had witnessed the potential of personalized cancer medicines. One patient has been kept alive despite being diagnosed in 2011 with an aggressive form of brain cancer called glioblastoma. The same cancer killed the former US vice-president Joe Biden’s son, Beau, who died in 2015, and former British cabinet minister Tessa Jowell, last month.

Cancer research is increasingly pushing for patients to have tumors sequenced for personalized treatment after analyzing key details within the DNA.

Some types of genetic testing are already on the market. Another major study presented at the conference found that many women with the most common form of early breast cancer do not benefit from chemotherapy. That test looked only at 21 genes.

Researchers believe more detailed genetic testing is on the horizon.

Dr Catherine Diefenbach, an Asco expert, said scientists had barely “scratched the surface” of the potential of precision medicine.

“Now with faster and more robust genetic tests, we can help even more patients by treating the cancer based on its genetic makeup rather than solely on its location in the body,” she said.

The Guardian

avatar Josephine O'Brien

Author: Josephine O'Brien, Community Manager UK

Josephine is the Community Manager of the UK with a Master’s in Publishing. She is a strong believer in the power of words and strives to make Carenity UK a comforting, vibrant and informative community for both... >> Learn more

Comments

You will also like

World Cancer Day: Facts and Insights!

Adamantinoma
Adrenocortical carcinoma
Anaplastic large cell lymphoma
Bladder cancer
Brain tumour
Breast cancer
Cancer
Catecholamine-secreting tumour
Cervical cancer
Colorectal cancer
Cutaneous lymphoma
Cutaneous T-cell lymphoma
Diffuse large B-cell lymphoma
Endocrine cancer
Endocrine tumour
Endometrial cancer
Enteropancreatic endocrine tumour
Ewing sarcoma
Follicular lymphoma
Gallbladder cancer
Gastrointestinal stromal tumour
Glial tumour
Hodgkin lymphoma
Kaposi sarcoma
Larynx cancer
Leukemia
Liver cancer
Lung cancer
Malignant tumour of the fallopian tube
Mantle cell lymphoma
Merkel tumour
Mesothelioma
Multiple endocrine neoplasia
Multiple myeloma
Nephroblastoma
Neuroblastoma
Non-Hodgkin lymphoma
Ollier disease
Osteosarcoma
Pancreatic cancer
Pheochromocytoma
Primary peritoneal tumour
Prostate cancer
Pseudomyxoma peritonei
Rare bone tumour
Renal cancer
Rhabdoid tumour
Sézary syndrome
Skin cancer
Small cell lung cancer
Squamous cell carcinoma of head and neck
Systemic mastocytosis
Testicular cancer
Thyroid cancer
Tumours of the heart
Waldenström macroglobulinemia
xyz_Colon cancer

World Cancer Day: Facts and Insights!

Read the article
Telling patients to 'fight' cancer puts them under pressure

Adamantinoma
Adrenocortical carcinoma
Anaplastic large cell lymphoma
Bladder cancer
Brain tumour
Breast cancer
Cancer
Catecholamine-secreting tumour
Cervical cancer
Colorectal cancer
Cutaneous lymphoma
Cutaneous T-cell lymphoma
Diffuse large B-cell lymphoma
Endocrine cancer
Endocrine tumour
Endometrial cancer
Enteropancreatic endocrine tumour
Ewing sarcoma
Follicular lymphoma
Gallbladder cancer
Gastrointestinal stromal tumour
Glial tumour
Hodgkin lymphoma
Kaposi sarcoma
Larynx cancer
Leukemia
Liver cancer
Lung cancer
Malignant tumour of the fallopian tube
Mantle cell lymphoma
Merkel tumour
Mesothelioma
Multiple endocrine neoplasia
Multiple myeloma
Nephroblastoma
Neuroblastoma
Non-Hodgkin lymphoma
Ollier disease
Osteosarcoma
Pancreatic cancer
Pheochromocytoma
Primary peritoneal tumour
Prostate cancer
Pseudomyxoma peritonei
Rare bone tumour
Renal cancer
Rhabdoid tumour
Sézary syndrome
Skin cancer
Small cell lung cancer
Squamous cell carcinoma of head and neck
Systemic mastocytosis
Testicular cancer
Thyroid cancer
Tumours of the heart
Waldenström macroglobulinemia
xyz_Colon cancer

Telling patients to 'fight' cancer puts them under pressure

Read the article
Cancer death rate to be cut by 22,000 using artificial intelligence – PM

Cancer

Cancer death rate to be cut by 22,000 using artificial intelligence – PM

Read the article
Lung cancer destroyed with tea leaf nanoparticles

Bladder cancer
Brain tumour
Breast cancer
Cancer
Cervical cancer
Endocrine cancer
Endometrial cancer
Gallbladder cancer
Gastrointestinal stromal tumour
Larynx cancer
Liver cancer
Pancreatic cancer
Prostate cancer
Renal cancer
Testicular cancer
Thyroid cancer
xyz_Colon cancer

Lung cancer destroyed with tea leaf nanoparticles

Read the article

Most commented discussions

Fact sheets